Iteos Therapeutics Inc (ITOS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
5.65 +0.47 (+9.07%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 5.65 unch (unch) 16:00 ET
for Fri, Apr 11th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ITOS | YMAB | LFCR | ||
| Company | Iteos Therapeutics Inc | Y-Mabs Therapeutics Inc | Lifecore Biomedical Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.21 | 4.40 | 5.85 | ||
| High | 5.67 | 4.88 | 5.94 | ||
| Low | 5.11 | 4.39 | 5.62 | ||
| Last | 5.65 | 4.83 | 5.82 | ||
| Change | +0.47 | +0.48 | +0.11 | ||
| % Change | +9.07% | +11.03% | +1.84% | ||
| Volume | 367,400 | 217,100 | 236,700 | ||
| 20-Day Average Volume | 332,775 | 328,965 | 369,050 | ||
| Previous Close | 5.18 | 4.35 | 5.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.15 | 4.70 | 6.39 | ||
| 20-Day Raw Stochastic | 32.20% | 66.44% | 41.09% | ||
| 20-Day Relative Strength | 39.44% | 46.30% | 45.52% | ||
| Weighted Alpha | -59.24 | -64.41 | +1.97 | ||
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.82% since 04/04/25 | +6.39% since 04/04/25 | +10.02% since 04/04/25 | ||
| Low | 4.80 on 04/09/25 | 3.86 on 04/09/25 | 4.76 on 04/07/25 | ||
| High | 5.67 on 04/11/25 | 4.88 on 04/11/25 | 6.54 on 04/09/25 | ||
| 1-Month | |||||
| %Chg | -19.97% since 03/11/25 | -2.23% since 03/11/25 | -9.06% since 03/11/25 | ||
| Low | 4.80 on 04/09/25 | 3.86 on 04/09/25 | 4.76 on 04/07/25 | ||
| High | 7.65 on 03/13/25 | 5.32 on 03/24/25 | 7.34 on 04/02/25 | ||
| 3-Month | |||||
| %Chg | -27.19% since 01/10/25 | -29.90% since 01/10/25 | -7.47% since 01/10/25 | ||
| Low | 4.80 on 04/09/25 | 3.86 on 04/09/25 | 4.76 on 04/07/25 | ||
| High | 8.31 on 01/21/25 | 7.03 on 01/13/25 | 7.34 on 04/02/25 | ||
| 6-Month | |||||
| %Chg | -43.22% since 10/11/24 | -66.69% since 10/11/24 | +25.97% since 10/11/24 | ||
| Low | 4.80 on 04/09/25 | 3.86 on 04/09/25 | 4.51 on 10/16/24 | ||
| High | 10.10 on 10/14/24 | 16.11 on 11/07/24 | 7.99 on 11/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 215,796 | 218,403 | 215,486 | ||
| Shares Outstanding, K | 38,194 | 45,218 | 37,025 | ||
| Annual Sales | 35,000,000 | 87,690,000 | 128,260,000 | ||
| Annual Net Income | -134,410,000 | -29,670,000 | 12,010,000 | ||
| Last Quarter Sales | 0 | 26,500,000 | 35,150,000 | ||
| Last Quarter Net Income | -45,360,000 | -6,790,000 | -14,770,000 | ||
| 60-Month Beta | 1.43 | 0.71 | 0.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.01 on 03/05/25 | -0.15 on 03/04/25 | -0.19 on 04/03/25 | ||
| Latest Earnings Date | 05/09/25 | 05/06/25 | 04/03/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||